OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
2.900
-0.090 (-3.01%)
Nov 4, 2024, 4:00 PM EST - Market closed

OncoCyte Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
1.021.50.962.21.22-
Upgrade
Revenue Growth (YoY)
-7.08%56.89%-56.41%80.76%--
Upgrade
Cost of Revenue
0.7110.880.71.86-
Upgrade
Gross Profit
0.310.50.081.5-0.64-
Upgrade
Selling, General & Admin
12.3513.5421.5320.3922.4515.45
Upgrade
Research & Development
9.519.157.284.89.436.79
Upgrade
Operating Expenses
21.9522.7728.9125.2831.8722.24
Upgrade
Operating Income
-21.63-22.27-28.83-23.77-32.51-22.24
Upgrade
Interest Expense
-0.05-0.05-0.08-0.21-0.25-
Upgrade
Interest & Investment Income
-----0.3
Upgrade
Earnings From Equity Investments
----0.27-1.55-0.28
Upgrade
Other Non Operating Income (Expenses)
0.660.39-0.06-0.040.03-0
Upgrade
EBT Excluding Unusual Items
-21.03-21.93-28.98-24.29-34.29-22.22
Upgrade
Merger & Restructuring Charges
-0.59-0.59-1.5-2.69-1.21-
Upgrade
Impairment of Goodwill
---18.68---
Upgrade
Gain (Loss) on Sale of Investments
-0.16-0.06-0.470.230.3-0.05
Upgrade
Gain (Loss) on Sale of Assets
-1.28-1.28----
Upgrade
Asset Writedown
-0.69-6.76----
Upgrade
Other Unusual Items
-12.395.7631.02-26.134.01-0.15
Upgrade
Pretax Income
-36.14-24.86-18.61-52.87-31.19-22.43
Upgrade
Income Tax Expense
----9.26-1.25-
Upgrade
Earnings From Continuing Operations
-36.14-24.86-18.61-43.61-29.93-22.43
Upgrade
Earnings From Discontinued Operations
--2.93-54.29-20.49--
Upgrade
Net Income
-36.14-27.78-72.9-64.1-29.93-22.43
Upgrade
Preferred Dividends & Other Adjustments
0.660.940.52---
Upgrade
Net Income to Common
-36.8-28.72-73.42-64.1-29.93-22.43
Upgrade
Shares Outstanding (Basic)
986433
Upgrade
Shares Outstanding (Diluted)
986433
Upgrade
Shares Change (YoY)
45.19%38.10%24.61%35.80%27.65%35.52%
Upgrade
EPS (Basic)
-3.91-3.75-13.25-14.42-9.14-8.74
Upgrade
EPS (Diluted)
-3.91-3.75-13.25-14.42-9.14-8.74
Upgrade
Free Cash Flow
-18.5-23.61-49.91-38.19-27.21-20.63
Upgrade
Free Cash Flow Per Share
-1.96-3.09-9.01-8.59-8.31-8.04
Upgrade
Gross Margin
30.69%33.33%8.14%68.29%-52.55%-
Upgrade
Operating Margin
-2114.76%-1481.57%-3009.50%-1081.62%-2673.77%-
Upgrade
Profit Margin
-3597.65%-1911.04%-7664.09%-2916.15%-2461.51%-
Upgrade
Free Cash Flow Margin
-1808.11%-1570.59%-5209.60%-1737.40%-2237.42%-
Upgrade
EBITDA
-20.22-20.59-23.61-19.57-32.12-21.9
Upgrade
D&A For EBITDA
1.411.685.224.210.390.34
Upgrade
EBIT
-21.63-22.27-28.83-23.77-32.51-22.24
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.